Clinical trials: Nontherapeutic
Healthy
Implant Pharmacokinetic and Pharmacodynamic Study
This is a single center, pharmacokinetic and pharmacodynamic study in healthy volunteers. Twenty four subjects will be enrolled in the study and will be assigned to receive either a 16 mg afamelanotide bioresorbable implant from…
- Trial name
- NCT03634137
- Testing
- Afamelanotide Group 1, Afamelanotide Group 2
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Clinuvel Pharmaceuticals Limited
Nontherapeutic
Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation
The purpose of this study is to use Randomized Controlled Trial (RCT) methods to examine the influence of novel tobacco products on biomarkers of toxicant exposure and disease risk, reports of adverse events, and concurrent use…
- Trial name
- NCT02342795
- Testing
- e-cigarette, cigarette substitute
- Where
- 2 sites in United States
- Volunteers
- 520 people, healthy volunteers welcome
- Sponsor
- Virginia Commonwealth University
Healthy
Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults
This is the first study of MTP-131 (Bendavia™) in humans. The objective of this study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single intravenous infusion doses of MTP-131.
- Trial name
- NCT01115920
- Testing
- MTP-131 (Bendavia™)
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Mighty Therapeutics, Inc.